(1) | (10) | " (1) | * (1) | 1 (4) | 2 (78) | 4 (1) | 6 (1) | A (203) | B (82) | C (846) | D (139) | E (93) | F (46) | G (50) | H (79) | I (89) | J (26) | K (37) | L (44) | M (111) | N (69) | O (46) | P (260) | Q (26) | R (57) | S (257) | T (149) | U (46) | V (40) | W (65) | X (7) | Y (8) | Z (6) | { (2) |   (3) | イ (1) | 用 (1) | 資 (1)
Title Author Last update
Richard Lewis awhite@cdisc.org Wednesday, June 8, 2022 - 17:59
Ruiling Peng awhite@cdisc.org Wednesday, June 8, 2022 - 18:06
Rare-x kvo Monday, August 8, 2022 - 14:54
Richann Watson syousef@cdisc.org Wednesday, October 12, 2022 - 11:02
Rates & Benefits - 2023 admincal Friday, December 2, 2022 - 18:53
RTI International d8_migrate Monday, March 6, 2023 - 13:03
Rheumatoid Arthritis Swollen/Tender Joint Count Assessment admincal Thursday, June 29, 2023 - 11:31
Rheumatoid Arthritis Joint Space Narrowing Assessment - Sharp/Genant admincal Thursday, June 29, 2023 - 11:32
Rheumatoid Arthritis Joint Space Narrowing Assessment - Sharp/Van der Heijde admincal Thursday, June 29, 2023 - 11:32
Rutgeerts Score mkirwin@cdisc.org Wednesday, September 6, 2023 - 11:26
Rho, Inc. admincal Wednesday, November 8, 2023 - 12:48
Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST 1.1) mkirwin@cdisc.org Wednesday, November 15, 2023 - 10:20
Rocket Pharmaceuticals, Inc. kvo Tuesday, December 5, 2023 - 15:18
REDCap Cloud cdisc-support@… Friday, December 8, 2023 - 11:32
Relay Therapeutics Anonymous (not verified) Friday, December 8, 2023 - 11:42
Reata Pharmaceuticals Anonymous (not verified) Friday, December 8, 2023 - 11:54
Revolution Medicines, Inc. Anonymous (not verified) Friday, December 8, 2023 - 11:55
Rare Diseases Therapeutic Area User Guide awhite@cdisc.org Thursday, December 14, 2023 - 16:41
Rates & Benefits admincal Thursday, March 14, 2024 - 12:44
Resolutum Global stephan.mynhar… Tuesday, March 19, 2024 - 01:15
RWD Lineage admincal Tuesday, April 9, 2024 - 12:57